#SFHS2608520VNotice on the Decision of the National Union of Health Insurance Funds Setting the Insured's Participation Rate for Pharmaceutical Specialties
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law updates the insured participation rate for certain pharmaceutical products, specifically two dosage forms of the drug OFEV. The rate is set at 70%, affecting patients using these medications under the French health insurance system.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Updated participation rate for OFEV medication.
- Set rate at 70% for two OFEV dosage forms.
Obligations
What this law requires
Implement the participation rate decision effective from the decision date of 12 February 2026
Apply a 70% insured participation rate to OFEV 25 mg (nintédanib) soft capsules in boxes of 120 units (CIP code 34009 303 089 3 6)
Apply a 70% insured participation rate to OFEV 25 mg (nintédanib) soft capsules in boxes of 180 units (CIP code 34009 303 089 4 3)